Clinical Trial Update: Prophylaxis of Graft-versus-host Disease With Anti-CD25 Antibody in Patients Underwent HSCT [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating anti-CD25 antibody for prophylaxis of graft-versus-host disease in patients undergoing hematopoietic stem cell transplantation…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• anti-CD25 antibody (cd25-targeting antibody)

Snippet

Sponsor: Wang Xin | Conditions: GVHD | Phase 2 | Status: UNKNOWN